10-KPeriod: FY2020

RTX Corp Annual Report, Year Ended Dec 31, 2020

Filed February 8, 2021For Securities:RTX

Summary

Raytheon Technologies Corporation (RTX) completed a transformative year in 2020, marked by the significant merger with Raytheon Company and the spin-off of its commercial businesses (Carrier and Otis). This strategic restructuring created a more focused aerospace and defense powerhouse. However, the company faced substantial headwinds in 2020, primarily due to the severe impact of the COVID-19 pandemic on its commercial aerospace segments, Collins Aerospace and Pratt & Whitney. These segments experienced significant declines in demand, leading to reduced sales and necessitating substantial restructuring charges, including a significant goodwill impairment of $3.2 billion within Collins Aerospace. Despite these challenges, the defense-oriented segments, Raytheon Intelligence & Space (RIS) and Raytheon Missiles & Defense (RMD), showed resilience and are expected to benefit from continued government spending. RTX is actively managing costs, preserving capital, and focusing on integration synergies post-merger. Investors should monitor the pace of recovery in the commercial aerospace sector and the ongoing execution of the company's integration and cost-saving initiatives.

Financial Highlights

56 data points
Beta

Revenue

$56.59B

Net Income

-$3.52B

-6.2% Net Margin

EPS (Diluted)

$-2.59

Total Assets

$162.15B

Cash & Equivalents

$8.80B

Free Cash Flow

$2.54B

Financial Statements
Beta
Revenue$56.59B
R&D Expenses$2.58B
SG&A Expenses$5.54B
Operating Expenses$56.18B
Operating Income-$1.89B
Interest Expense$1.37B
Net Income-$3.52B
EPS (Basic)$-2.59
EPS (Diluted)$-2.59
Shares Outstanding (Basic)1.36B
Shares Outstanding (Diluted)1.36B

Key Highlights

  • 1Completion of the Raytheon Merger and spin-off of commercial businesses in April 2020, forming a new, integrated aerospace and defense entity.
  • 2Significant negative impact from the COVID-19 pandemic on commercial aerospace segments (Collins Aerospace and Pratt & Whitney), leading to reduced sales and operational adjustments.
  • 3Recorded a substantial goodwill impairment of $3.2 billion in the Collins Aerospace segment due to COVID-19 related impacts.
  • 4Defense segments (RIS and RMD) remained resilient and are expected to be key growth drivers.
  • 5Implemented significant cost mitigation strategies, including R&D and capital expenditure reductions, and workforce adjustments.
  • 6Total net sales for 2020 were $56.6 billion, a significant increase driven by the Raytheon Merger, but with organic sales declining due to commercial aerospace pressures.
  • 7The company ended 2020 with $8.8 billion in cash and cash equivalents, demonstrating a focus on liquidity preservation.

Frequently Asked Questions

The COVID-19 pandemic significantly impacted Raytheon Technologies, particularly its commercial aerospace businesses (Collins Aerospace and Pratt & Whitney). The sharp decline in air travel led to reduced demand for aircraft parts and services, aircraft production rate cuts by manufacturers, and deferrals of maintenance. This resulted in lower sales and necessitated cost-saving measures, including workforce reductions and a substantial goodwill impairment charge.

The most significant financial events were the completion of the merger with Raytheon Company, forming Raytheon Technologies Corporation, and the spin-off of its former commercial businesses, Carrier and Otis. The company also recorded a $3.2 billion goodwill impairment charge in its Collins Aerospace segment due to the pandemic's impact. The company's total net sales increased significantly due to the merger, but organic sales declined.

The merger created a larger, more diversified aerospace and defense company with four primary segments: Collins Aerospace, Pratt & Whitney, Raytheon Intelligence & Space, and Raytheon Missiles & Defense. The merger significantly increased the company's scale, backlog, and U.S. government sales exposure. It also led to substantial goodwill and intangible assets on the balance sheet.

The company expects its commercial aerospace businesses (Collins Aerospace and Pratt & Whitney) to continue to be significantly negatively impacted in the near term due to the ongoing effects of the COVID-19 pandemic. While the long-term outlook for air travel demand is considered positive, the recovery to pre-pandemic levels is not anticipated until 2023 or 2024. The company is actively managing costs and adjusting production schedules in response to current demand.